News

BioM's articles and press releases about the Bavarian biotechnology sector


2nd Immunotherapy of Cancer Conference itoc-2 in Munich

The second ITOC (Im­mun­o­ther­apy of Can­cer) Con­gress took place at the premises of Klinikum rechts der Isar der Tech­nis­chen…

Medigen´s T cell receptor technology highlighted in Nature Biotechnology

The pos­it­ive re­search res­ults presen­ted show an im­port­ant sci­entif­ic found­a­tion for the clin­ic­al de­vel­op­ment of the…

Ultrafast detection of Ebola Virus - GNA Biosolution leads an European consortium

FILODIAG pro­ject for real time Laser PCR dia­gnos­is in less than 15 min.

LifeScience Conference in Munich-Garching in March

The or­gan­izers ex­pect around 1,000 par­ti­cipants from 20 coun­tries and over 100 ex­hib­it­ors.

German Biotech Pieris (Freising near Munich) goes public in USA

Re­verse mer­ger with formerly Marika Inc., Nevada.

New report: European metropolitan area of Munich is top location for biotechnology and pharmaceutical industries

Ac­cord­ing to a rank­ing of “Gen­et­ic Engin­eer­ing & Bi­o­tech­no­logy News, GEN”, March 2014, (www.gen­eng­news.com), the Mu­nich…

Biotech Outsourcing Strategies cmc 2015

For the part­ner­ing event fo­cus­sing on Chem­istry/Man­u­fac­ture/Con­trols in Mu­nich on June 10-11, 2015, Bav­ari­an bi­otechs re­ceive…

4th Munich Biomarker Conference

The in­ter­dis­cip­lin­ary pro­gramme of the European Net­work­ing Event for Per­son­al­ized Medi­cine on Novem­ber 25th-26th, 2014 is now…

MorphoSys has now 3 antibodies in phase-3 - with pharma partners

Roche, No­vartis and now Janssen are the 3 big pharma, whose part­ner­ing pro­grammes with a spe­cif­ic MOR an­ti­body have already reached…

Made in Munich: Amgen heading for "Bite" approval

The Amer­ic­an bi­otech giant Amgen has sub­mit­ted an ap­plic­a­tion to the im­mun­omolecule blinatumomab, a bis­pe­cif­ic an­ti­body…